Travere Therapeutics, Inc. (TVTX)
35.82
+1.42
(+4.11%)
USD |
NASDAQ |
Dec 11, 13:46
Travere Therapeutics EPS Diluted (Quarterly): 0.2505 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | -0.1888 |
| Edwards Lifesciences Corp. | 0.5004 |
| Intuitive Surgical, Inc. | 1.947 |
| Stryker Corp. | 2.221 |
| iRhythm Technologies, Inc. | -0.162 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.71M |
| Revenue (Quarterly) | 164.86M |
| Total Expenses (Quarterly) | 139.15M |
| Enterprise Value | 3.154B |
| Gross Profit Margin (Quarterly) | 89.46% |
| Profit Margin (Quarterly) | 15.59% |
| Earnings Yield | -3.03% |
| Normalized Earnings Yield | -2.995 |